cdmo.directory
← Compare landing

Almac Group vs Crystec Limited (CrystecPharma)

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAlmac GroupCrystec Limited (CrystecPharma)
SummaryGlobal CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities.Crystec Limited (CrystecPharma) is a pharmaceutical technology company that offers its mSAS® supercritical-fluid particle engineering platform to improve the bioavailability, stability and delivery of small and large molecule therapeutics. Its work is aimed at clients developing new and existing medicines.
Services
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Flow Chemistry & Continuous Manufacturing
  • Solid-State Chemistry & Polymorph Screening
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Oligonucleotide Manufacturing
  • Peptide Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Cartridge Filling
  • Lyophilization (Freeze Drying)
  • Oral Solid Dosage Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • Extractables & Leachables Studies
  • Secondary Packaging & Labeling
  • Serialization & Track-and-Trace
  • Cold-Chain Storage & Logistics
  • Combination Product Assembly & Final Packaging
  • CMC Regulatory Submission Support
  • Solid-State Chemistry & Polymorph Screening
  • Inhalation & Nasal Dosage Manufacturing
  • Process Development
  • Formulation Development
Modalities
  • Small Molecule
  • Biologics (Other)
  • Oligonucleotide
  • Peptide
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Oligonucleotide
  • Peptide
Development capabilities
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Solid-state characterization
  • Cell line development
  • Formulation development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Oral Solid Dose (OSD)
  • Liquid Vials
  • Lyophilized Vials
  • Prefilled Syringes (PFS)
  • HPAPI
  • Flow Chemistry
  • Hydrogenation
Data not yet provided.
Locations
  • Headquarters, Belfast, Northern Ireland, United Kingdom
  • US Operations, Multiple, United States, United States
  • Partner Lab, Multiple, Asia, Asia
  • Headquarters / UK, UK, United Kingdom
  • US, US, United States
  • Asia Partner Lab, Asia
  • Headquarters, Craigavon, Northern Ireland, United Kingdom
  • Souderton, Souderton, Pennsylvania, United States
  • Singapore, Singapore, Singapore, Singapore
  • Craigavon, Craigavon, Northern Ireland, United Kingdom
  • North Carolina, North Carolina, North Carolina, United States
  • Bradford (Headquarters), Bradford, United Kingdom
  • Tianjin, Tianjin, China
  • Hangzhou (Inhalatec), Hangzhou, China
  • Lugano (Inhalis), Lugano, Switzerland
Certifications
  • GMP · Identifier: GMP
Data not yet provided.

Find similar companies

Almac Group alternatives · Crystec Limited (CrystecPharma) alternatives

Markdown mirror: /compare/almacgroup/crystecpharma.md